Mp. Montanari et al., In vitro antibacterial activities of AF 3013, the active metabolite of prulifloxacin, against nosocomial and community Italian isolates, ANTIM AG CH, 45(12), 2001, pp. 3616-3622
AF 3013, the active Metabolite of prulifloxacin, was tested to determine it
s inhibitory and bactericidal activities against 396 nosocomial and 258 com
munity Italian isolates. Compared with that of ciprofloxacin, its activity
(assessed in MIC and minimal bactericidal concentration tests) was generall
y similar or greater against gram-positive bacteria and greater against gra
m-negative bacteria. In time-kill assays using selected isolates, its bacte
ricidal activity was comparable to that of ciprofloxacin.